Home

Jagsonpal Pharmaceuticals Ltd PB Ratio

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

PB

8.6

Last updated on: 22 Nov 24

Key Highlights

  • The latest PB Ratio of Jagsonpal Pharmaceuticals Ltd is 8.6.
  • The PB ratio of the Jagsonpal Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Jagsonpal Pharmaceuticals Ltd changed from 0.7 on March 2019 to 4 on March 2024 . This represents a CAGR of 33.71% over 6 years.

Historical P/B Ratio of Jagsonpal Pharmaceuticals Ltd

No data available

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

Market Cap

1,697 Cr

EPS

10.1

P/E Ratio (TTM)

63.5

P/B Ratio (TTM)

8.6

Day’s High

654.95

Day’s Low

583.55

DTE

0.0

ROE

13.6

52 Week High

654.95

52 Week Low

270.05

ROCE

17.5

Market Price of Jagsonpal Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024640.2
21 Nov 2024591.65
19 Nov 2024578.1
18 Nov 2024591.7
14 Nov 2024533.2

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

Company
leftPBright
Jagsonpal Pharmaceuticals Ltd8.61
Sun Pharmaceuticals Industries Ltd98.3
Divis Laboratories Ltd513.6
Cipla Ltd360.7
Torrent Pharmaceuticals Ltd222.4

Historical Market Cap of Jagsonpal Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Jagsonpal Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

FAQs for PB Ratio of Jagsonpal Pharmaceuticals Ltd

What is the PB ratio of Jagsonpal Pharmaceuticals Ltd?

The current PB ratio of Jagsonpal Pharmaceuticals Ltd is 8.61. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Jagsonpal Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Jagsonpal Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Jagsonpal Pharmaceuticals Ltd calculated?

The PB ratio of Jagsonpal Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Jagsonpal Pharmaceuticals Ltd?

A high PB ratio suggests that Jagsonpal Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Jagsonpal Pharmaceuticals Ltd?

A low PB ratio of Jagsonpal Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Jagsonpal Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Jagsonpal Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*